First Analysis analyst Steven Schwartz raised his price target for Catalent to $49 and maintains an Outperform rating on the shares following meetings with management. . The company has a “relatively modest” organic growth profile, but there is additional growth potential from margin expansion driven by business mix improvement and leverageable acquisitions, Schwartz tells investors in a research note.
https://thefly.com/landingPageNews.php?id=2874177
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.